National expert consensus on home-administered oncologic therapies in Spain.

Journal Information

Full Title: Front Oncol

Abbreviation: Front Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest Authors MA and MC were employed by the company Pharmacoeconomics & Outcomes Research Iberia (PORIB). Author YS was employed by the company Eisai Farmaceutica S.A. All authors have received honoraria from Eisai Pharmaceuticals S.A. The authors declare that this study received funding from Eisai Farmaceutica, S.A. The funder had the following involvement in the study: responsible for contacting the project coordinator, setting the project goals, and developing the initial work plan. It was also in charge of gathering information from different sources about professional experts that could be invited to join in and, along with the project coordinator, invite them. Eisai provided the logistic support for the meetings (all via teleconference), selected the medical writing agency and the funding for the professional participants fees and external medical writer honorarium. Two members of the local Oncology Medical Affairs Department attended to the expert discussion meetings as observers, but they have not righted to review or modify the manuscript and the final consensus document."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025